![Societe Generale Effekten](/common/images/company/BIT_S31873.png)
TORONTO, Canada -- March 24, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company...
TORONTO, Canada -- March 16, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company...
TORONTO, Canada -- February 18, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) ("Cybin" or the "Company"), a biopharmaceutical...
- Cybin's holistic and innovative approach to developing improved treatment options for patients aligns with the goals of the Foundation's NeverAlone Initiative - - Fireside chat...
- Composition of matter patent strengthens proprietary position of CYB004 as a deuterated DMT compound until 2041- TORONTO, Canada -- February 9, 2022 -- InvestorsHub NewsWire...
TORONTO, Canada -- January 27, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company...
-Enrollment expected to begin in early 2022 - TORONTO, Canada -- January 11, 2022 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin"...
TORONTO, Canada -- December 22, 2021 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical...
TORONTO, Canada -- December 21, 2021 -- InvestorsHub NewsWire -- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.